Company name:
HealthEquity Inc
-
IPO SHARE PRICE:$14.00
-
IPO DATE:July 31, 2014
-
TICKER:HQY
-
MAIN STOCK EXCHANGE:NASDAQ
-
CURRENT HQ LOCATION:15 West Scenic Pointe Drive Suite 100 Draper Utah 84020
-
FISCAL YEAR END:January 31
-
INCORPORATION JURISDICTION:DE
-
ORGANIZED AS THE FOLLOWING LEGAL TYPE:Corporation
-
Investor Relations Webpage:Coming soon!
-
TAX RATE:USA federal corporate nominal income tax rate is 21%
Short Description
HealthEquity Inc
We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com
Statement of Cash Flow
(USD in thousand)
Selected Year:
31-Jan
2021
2021
OPERATING ACTIVITIES
Cash received and spent on operating activites of business — buying materials, paying salaries, receiving payments from clients, etc
52.0% -
Depreciation and amortization
19.2% -
Stock-based compensation
13.7% -
Accounts payable accrued expenses and other liabilities
5.0% -
Operating lease right-of-use assets
4.0% -
Net income (loss)
2.7% -
Other liabilities
2.3% -
Amortization of debt issuance costs
0.8% -
Other non-cash items
0.3% -
Accrued compensation and employee benefits
SOURCEs
5.0%
52.0%
13.7%
19.2%
4.0%
100 %
0%
USES
81.5%
11.1%
4.8%
11.1% -
Other assets
4.8% -
Operating lease liabilities
2.3% -
Deferred income taxes
0.2% -
Accounts receivable
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | $73,899 | $39,664 | $8,834 | $8,834 | $21,468 | ||||||
|
Depreciation and amortization
|
18,185 | 55,352 | 115,904 | 115,904 | 121,676 | ||||||
|
Amortization of debt issuance costs
|
60 | 2,711 | 5,102 | 5,102 | 5,136 | ||||||
|
Amortization of deferred financing costs
|
- | - | - | - | - | ||||||
|
Amortization of deferred financing costs and loss on other investments
Amortization of deferred financing costs and loss on other investments
|
- | - | - | - | - | ||||||
|
Stock-based compensation
|
21,057 | 39,844 | 42,863 | 42,863 | 50,200 | ||||||
|
Provision for (recovery of) bad debt expense
|
240 | - | - | - | - | ||||||
|
Imputed interest on notes payable
|
- | - | - | - | - | ||||||
|
Deferred income taxes
|
408 | 3,665 | (5,132) | (5,132) | (16,636) | ||||||
|
Loss on disposal of software development costs and other
Loss on disposal of software development costs and other
|
933 | - | - | - | - | ||||||
|
(Gains) losses on marketable securities
|
1,173 | (23,151) | - | - | - | ||||||
|
(Gains) losses on marketable equity securities
|
103 | (27,570) | - | - | - | ||||||
|
Loss on other investments
|
- | - | - | - | - | ||||||
|
Loss on revaluation of redeemable convertible preferred stock derivative
Loss on revaluation of redeemable convertible preferred stock derivative
|
- | - | - | - | - | ||||||
|
Loss on revaluation of warrant liability
|
- | - | - | - | - | ||||||
|
Other non-cash items
|
676 | 728 | 1,753 | 1,753 | 104 | ||||||
|
Accounts receivable
|
(4,306) | (5,009) | (413) | (413) | (33,904) | ||||||
|
Operating lease right-of-use assets
|
- | 6,218 | 11,150 | 11,150 | 11,224 | ||||||
|
Inventory
|
- | - | - | - | - | ||||||
|
Prepaid expenses and other assets
|
- | - | - | - | - | ||||||
|
Restricted cash and cash equivalents
|
- | - | - | - | - | ||||||
|
Other assets
|
(5,893) | (12,577) | (24,839) | (24,839) | (112,592) | ||||||
|
Accounts payable
|
863 | (3,839) | - | - | - | ||||||
|
Accounts payable accrued expenses and other liabilities
Accounts payable accrued expenses and other liabilities
|
3,894 | 1,920 | 30,422 | 30,422 | 153,432 | ||||||
|
Income tax payable
|
- | - | - | - | - | ||||||
|
Accrued liabilities
|
3,031 | - | - | - | - | ||||||
|
Accrued compensation and employee benefits
|
4,432 | 4,550 | 771 | 771 | 64,088 | ||||||
|
Due to trust
|
- | - | - | - | - | ||||||
|
Accrued and other liabilities
|
3,031 | 5,759 | - | - | - | ||||||
|
Deferred rent
|
- | - | - | - | - | ||||||
|
Operating lease liabilities
|
- | (5,383) | (10,803) | (10,803) | (9,768) | ||||||
|
Letter of credit cash deposit
|
- | - | - | - | - | ||||||
|
Other liabilities
|
573 | (83) | 6,007 | 6,007 | (10,820) | ||||||
| Net cash provided by (used in) operating activities | $113,422 | $105,010 | $181,619 | $181,619 | $243,608 |
Selected Year:
31-Jan
2021
2021
INVESTING ACTIVITIES
Cash spent on acquiring plant, equipment and other businesses, cash recei0 from sale of plant, equipment and subsidiaries as well cash parked temporarily in different securities - government bonds typically
SOURCEs
0%
100 %
0%
USES
53.1%
13.5%
33.4%
53.1% -
Purchase of software and capitalized software development costs
33.4% -
Purchases of intangible assets
13.5% -
(Purchase) sale of property and equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Purchases of marketable securities
|
(728) | (53,845) | - | - | - | ||||||
|
Sale of marketable securities
|
41,422 | - | - | - | - | ||||||
|
(Purchases) sale of a long-term investment
|
- | - | - | - | - | ||||||
|
(Purchases) sale of other investments
|
- | - | - | - | - | ||||||
|
(Purchase) sale of property and equipment
|
(3,869) | (7,286) | (13,093) | (13,093) | (6,820) | ||||||
|
Purchases of intangible assets
|
(1,195) | (9,134) | (32,371) | (32,371) | (17,084) | ||||||
|
Purchase of software and capitalized software development costs
Purchase of software and capitalized software development costs
|
(9,978) | (25,654) | (51,500) | (51,500) | (57,032) | ||||||
|
Note receivable from shareholder
|
- | - | - | - | - | ||||||
|
Acquisitions
|
- | (1,644,575) | - | - | - | ||||||
|
Acquisition of business net of cash
|
- | - | - | - | - | ||||||
| Net cash provided by (used in) investing activities | $25,652 | ($1,740,494) | ($96,964) | ($96,964) | ($80,936) |
Selected Year:
31-Jan
2021
2021
FINANCING ACTIVITIES
Items in this group are concerned with borrowing funds, repaying debt, issuing equity, buying back shares, etc.
97.1% -
Secondary (Follow-on) Public Offering net
2.9% -
Proceeds from issuance of common stock upon exercise of stock options
SOURCEs
97.1%
100 %
0%
USES
17.7%
80.9%
80.9% -
Repayment of long-term borrowing
1.3% -
Settlement of client-held funds obligation
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Initial Public Offering (IPO) net
|
- | - | - | - | - | ||||||
|
Secondary (Follow-on) Public Offering net
|
- | 458,495 | 286,779 | 286,779 | - | ||||||
|
Proceeds from issuance of common stock upon exercise of stock options
Proceeds from issuance of common stock upon exercise of stock options
|
22,929 | 11,347 | 8,568 | 8,568 | 16,308 | ||||||
|
Proceeds from exercise of common stock warrants
|
- | - | - | - | - | ||||||
|
Repayment of notes payable
|
- | - | - | - | - | ||||||
|
Long-term borrowing
|
- | 1,250,000 | - | - | - | ||||||
|
Repayment of long-term borrowing
|
- | (7,813) | (239,063) | (239,063) | (62,500) | ||||||
|
Debt issuance costs
|
- | (30,504) | - | - | - | ||||||
|
Deferred financing costs
|
- | - | - | - | - | ||||||
|
Tax benefit from stock-based compensation
|
- | - | - | - | - | ||||||
|
Dividends paid
|
- | - | - | - | - | ||||||
|
Repurchase of redeemable convertible preferred stock and convertible preferred stock
Repurchase of redeemable convertible preferred stock and convertible preferred stock
|
- | - | - | - | - | ||||||
|
Settlement of client-held funds obligation
|
- | (215,790) | (3,862) | (3,862) | 1,308 | ||||||
| Net cash provided by (used in) financing activities | $22,929 | $1,465,735 | $52,422 | $52,422 | ($44,884) |
Selected Year:
31-Jan
2021
2021
NET CHANGE IN CASH
Grand Total for sum of cash flows coming from operations, investing and financing
$137,077,000